Newbury Park, CA, United States of America

Olaf B Kinstler

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 1,133(Granted Patents)


Location History:

  • Oxnard, CA (US) (1998)
  • Thousand Oaks, CA (US) (1996 - 2012)
  • Newbury Park, CA (US) (1999 - 2012)

Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Olaf B. Kinstler

Introduction

Olaf B. Kinstler, based in Newbury Park, California, is a prolific inventor with a remarkable portfolio that includes 19 patents. His work primarily focuses on biochemistry, particularly in the development of modified proteins and therapeutic peptides. His innovative contributions have significantly advanced the realm of biotechnology.

Latest Patents

Among Kinstler's latest patents are groundbreaking developments in protein compositions and methods. One notable patent addresses N-terminally chemically modified protein compositions. This involves novel techniques for attaching water-soluble polymers to proteins, enhancing their effectiveness. Additionally, he has developed N-terminally chemically modified granulocyte-colony stimulating factor (G-CSF) compositions, detailing methods of preparation that improve therapeutic outcomes. Another significant invention relates to therapeutic peptides, which include compounds designed for improved bioefficacy in multi-dose administrations by incorporating an antibody Fc region and various water-soluble polymers.

Career Highlights

Throughout his career, Olaf Kinstler has made significant contributions to the biotechnology industry. He has worked with prominent companies such as Amgen Inc. and The General Hospital Corporation, where he has been instrumental in the development of innovative therapeutic solutions that address various health challenges.

Collaborations

Kinstler’s journey in innovation has been marked by teamwork and collaboration. He has worked alongside esteemed colleagues such as Nancy E. Gabriel and Christine E. Farrar, contributing his expertise to projects that have harnessed the power of biochemistry to solve complex medical problems.

Conclusion

Olaf B. Kinstler stands out as a key innovator in the field of biotechnology, with numerous patents that showcase his commitment to improving health outcomes through advanced science. His ongoing work continues to inspire future innovations and drive the industry forward, underscoring the vital role of inventors in addressing global health needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…